Clinical Trial Finder | Pancreatic Cancer Action Network

Back to Trial Search

Phase II Trial of Nivolumab and Ipilimumab and Radiation Therapy in Metastatic, Microsatellite Stable Pancreatic Cancer

Summary

The purpose of this phase II research is to study the effects of the combination of ipilimumab, nivolumab, and radiation therapy in patients with microsatellite stable pancreatic cancer.

General Information

NCT#: NCT04361162
Study ID: 19-587
Trial Phase: Phase II

Trial Sponsor: Bristol-Myers Squibb, Massachusetts General Hospital
Therapies Used in This Trial: Radiation Therapy, Ipilimumab, Nivolumab

Request a Healthcare Provider account to access Trial Eligibility and Site Information.

View Details

An authorized Healthcare Provider account is required to access Trial Eligibility and Site Information. Already have an account? Sign In

Request an Account

In order to view this information, you need to be signed in as a Health Care Provider.
You need to be signed in as a Health Care Provider. Please request an account.
In order to view this information, you need to be signed in as a Health Care Provider.
In order to see the trial eligibility criteria, you need to be signed in as a Health Care Provider.
This information is restricted to validated Health Care Providers.

Eligibility

-------------------------------------------------------------------------------------------

In order to view this information, you need to be signed in as a Health Care Provider.
You need to be signed in as a Health Care Provider. Please request an account by clicking on the Request button.
------------------------------------------------------------------------------------------------------
In order to view this information, you need to be signed in as a Health Care Provider. You are currently not authorized.

Site Information

Back to Trial Search